Friday, June 02, 2023 1:29:27 PM
I really like how you have used the opportunities to buy shares. Similarly, I recently re-invested a healthy sum into an offering last year based on Cecil and Gallagher's progress and improvements. Cecil knows QSEP inside and out, he knows what needs to be done to make both QSEP the company, and QSEP the stock a success. You and I are 100% on the same page when it comes to QSEP. No doubt it's taken fortitude to wait it out, but I think those that do will be handsomely rewarded. If QSEP sells the AOT in any way shape or form, or if they prove commercial viability in any way the value of the company imho will double triple quadruple, you name it. It's taken a long time and a lot of screw ups and learning to get to this stage, but I do think Gallagher has got it right. For me, despite the design flaws the AOT has been shown to reduce the viscosity of oil again and again during many tests. Excellent results, beyond what even the company had hoped. I have no doubt the AOT works and the tech is sound. But it has had design flaws. Once those are fixed imho it will show excellent results.
I absolutely think QSEP is back on the road to commercial viability given recent announcements. I have made a lot of money in the past with this stock, and I really think it is about to happen again. So I too would like to thank the babbling babblers for some great opportunities. I think .055 or a $20M valuation is dirt cheap if they get just one order, prove commercial viability, get a partnership, or really if anything for this company goes right. I think Cecil has the motivation and drive to get this done. So I think the things they are working on right now are important. Otherwise Cecil imho would not have said this publicly:
He would not have put this out there if he wasn't working on a big deal with a customer. It's obvious. So let's sit back and wait for what should be some very positive developments.
Recent QSEP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:39:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 01:05:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:52:03 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM